Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NeuBase Therapeutics, Inc. NBSE
$0.20
-$0.01 (-3.06%)
На 18:01, 12 мая 2023
+4 650.00%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
6664235.00000000
-
week52high
1.45
-
week52low
0.12
-
Revenue
0
-
P/E TTM
0
-
Beta
0.86025600
-
EPS
-0.93000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Chardan Capital | Buy | Buy | 12 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 31 мая 2022 г. |
| Chardan Capital | Buy | Buy | 13 мая 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 01 июн 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 12 февр 2021 г. |
| Oppenheimer | Perform | Outperform | 21 окт 2022 г. |
| RBC Capital | Sector Perform | Outperform | 18 окт 2022 г. |
| Chardan Capital | Neutral | Buy | 17 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Branning Todd P. | A | 200000 | 200000 | 03 ноя 2022 г. |
| Stephan Dietrich A | D | 2519680 | 750000 | 28 сент 2022 г. |
| Stephan Dietrich A | A | 816775 | 750000 | 28 сент 2022 г. |
| Ende Eric J | A | 37600 | 37600 | 09 сент 2022 г. |
| GOLDSTEIN DOV A MD | A | 37600 | 37600 | 09 сент 2022 г. |
| McDougall Gerald J | A | 37600 | 37600 | 09 сент 2022 г. |
| PRENDERGAST FRANKLYN G | A | 37600 | 37600 | 09 сент 2022 г. |
| RICHMAN ERIC I | A | 37600 | 37600 | 09 сент 2022 г. |
| Mann William Roland | A | 11200 | 6200 | 30 мар 2022 г. |
| Branning Todd P. | A | 30000 | 10000 | 18 мар 2022 г. |
Новостная лента
NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting
GlobeNewsWire
02 мая 2023 г. в 17:00
PITTSBURGH, May 02, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotechnology company developing Stealth Editors™ to perform in vivo gene editing without triggering the immune system, today announced two abstracts have been accepted for two oral presentations at the American Society of Gene & Cell Therapy (“ASGCT”) 26th Annual Meeting, which will take place in Los Angeles, CA and virtually on May 16-20, 2023.
What Makes NeuBase (NBSE) a New Strong Buy Stock
Zacks Investment Research
20 янв 2023 г. в 13:32
NeuBase (NBSE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for January 20th
Zacks Investment Research
20 янв 2023 г. в 07:32
NBSE, PRTG, RELL, HOWL and PATH have been added to the Zacks Rank #1 (Strong Buy) List on January 20, 2022.
Best Penny Stocks To Buy? 10 Under $1 To Watch This Week
PennyStocks
27 дек 2022 г. в 11:13
Penny stocks to buy for under $1 but are they worth the risk? The post Best Penny Stocks To Buy?
Best Penny Stocks To Buy? 6 Under $1 To Watch Now
PennyStocks
23 дек 2022 г. в 12:45
Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy?